Evidence map›Paper›PMID 38313099›Full record

ArticleWellcome open research2022

School and community driven dengue vector control and monitoring in Myanmar: Study protocol for a cluster randomized controlled trial.

Hans J Overgaard, Nay Yi Yi Linn, Aye Mon Mon Kyaw, Leo Braack, Myo Win Tin, Sheri Bastien, Fiona Vande Velde, Pierre Echaubard, Win Zaw, Mavuto Mukaka and 1 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Hans J OvergaardFaculty of Science and Technology, Norwegian University of Life Sciences, As, 1432, Norway.ORCID https://orcid.org/0000-0001-7604-3785
Nay Yi Yi LinnCentral Vector Borne Disease Control Unit, Ministry of Health and Sports, Nay Pyi Taw, Myanmar.
Aye Mon Mon KyawYangon Regional Health Department, Ministry of Health and Sports, Yangon, Myanmar.
Leo BraackMalaria Consortium, Bangkok 10400, Thailand.
Myo Win TinMalaria Consortium, Yangon 11041, Myanmar.
Sheri BastienFaculty of Landscape and Society, Norwegian University of Life Sciences, 1432 Ås, Norway.ORCID https://orcid.org/0000-0002-4351-5704
Fiona Vande VeldeFaculty of Landscape and Society, Norwegian University of Life Sciences, 1432 Ås, Norway.
Pierre EchaubardSchool of Oriental and African Studies (SOAS), University of London, London, WC1H 0XG, UK.
Win ZawMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.ORCID https://orcid.org/0000-0002-9852-3357
Mavuto MukakaMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.
Richard MaudeMahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.ORCID https://orcid.org/0000-0002-5355-0562
Mahidol University · THMalaria Consortium · GBHarvard University · USKhon Kaen University · THMinistry of Health · MMMinistry of Health and Sports · MMNorwegian University of Life Sciences · NOUniversity of Calgary · CA

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: Dengue is the most common and widespread mosquito-borne arboviral disease globally estimated to cause >390 million infections and >20,000 deaths annually. There are no effective preventive drugs and the newly introduced vaccines are not yet available. Control of dengue transmission still relies primarily on mosquito vector control. Although most vector control methods currently used by national dengue control programs may temporarily reduce mosquito populations, there is little evidence that they affect transmission. There is an urgent need for innovative, participatory, effective, and locally adapted approaches for sustainable vector control and monitoring in which students can be particularly relevant contributors and to demonstrate a clear link between vector reduction and dengue transmission reduction, using tools that are inexpensive and easy to use by local communities in a sustainable manner. Methods: Here we describe a cluster randomized controlled trial to be conducted in 46 school catchment areas in two townships in Yangon, Myanmar. The outcome measures are dengue cases confirmed by rapid diagnostic test in the townships, dengue incidence in schools, entomological indices, knowledge, attitudes and practice, behavior, and engagement. Conclusions: The trial involves middle school students that positions them to become actors in dengue knowledge transfer to their communities and take a leadership role in the delivery of vector control interventions and monitoring methods. Following this rationale, we believe that students can become change agents of decentralized vector surveillance and sustainable disease control in line with recent new paradigms in integrated and participatory vector surveillance and control. This provides an opportunity to operationalize transdisciplinary research towards sustainable health development. Due to the COVID-19 pandemic and political instability in Myanmar the project has been terminated by the donor, but the protocol will be helpful for potential future implementation of the project in Myanmar and/or elsewhere.Registration: This trial was registered in the ISRCTN Registry on 31 May 2022 ( https://doi.org/10.1186/ISRCTN78254298).

Indexed as

Aedescommunity engagementDengue incidenceimplementation fidelityKAPschool

Identifiers

PMID38313099
PMCPMC10837613
OpenAlexW4390345157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.